tiprankstipranks
Oryzon Genomics SA (ES:ORY)
BME:ORY
Holding ES:ORY?
Track your performance easily

Oryzon Genomics SA (ORY) Cash flow

9 Followers

Oryzon Genomics SA Cash Flow

ES:ORY's free cash flow for Q4 2022 was €―. For the 2022 fiscal year, ES:ORY's free cash flow was decreased by €-730.64K and operating cash flow was €―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
-€ -1.85M€ -3.63M€ -4.82M€ -3.93M€ -666.09K
Investing Cash Flow
-€ -14.27M€ -11.72M€ -9.08M€ -9.58M€ -6.98M
Financing Cash Flow
-€ 8.71M€ 4.12M€ 18.38M€ 14.26M€ 7.01M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-€ 21.32M€ 28.72M€ 39.60M€ 35.11M€ 34.32M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--€ 0.00€ 17.96M€ 18.30M€ 11.95M
Issuance Of Debt
-€ 14.07M€ 7.96M€ 7.07M€ 4.41M€ 1.92M
Repayment Of Debt
-€ -4.43M€ -3.84M€ -6.87M€ -8.52M€ -6.86M
Free Cash Flow
-€ -16.12M€ -15.39M€ -14.04M€ -13.52M€ -7.72M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

Oryzon Genomics SA Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis